KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need.
The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 6 Rue De Porstrein, Port De Commerce,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kalsiom.com
- HQ
- Brest
Kalsiom Sas Questions
Kalsiom Sas's website is http://www.kalsiom.com
Kalsiom Sas's LinkedIn profile is https://fr.linkedin.com/company/kalsiom-sas
Kalsiom Sas has
5 employees.
View email and phone details for 5
employees at Kalsiom Sas.
Kalsiom Sas's industry is
Biotechnology Research
Kalsiom Sas's top competitors are
Parean Biotechnologies,
Nh Theraguix,
Seabelife Biotech,
Oso-Ai,
Systol Dynamics,
Aberactives Sas,
Hemarina,
Beez Biotech,
Spiru’marine,
Kervrant Biotech.
Kalsiom Sas's categories are Biotechnology Research
Kalsiom Sas's founding year is 2020
